Global Octreotide Market Analysis and Forecast 2024-2030

Global Octreotide Market Analysis and Forecast 2024-2030


Summary

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

According to APO Research, The global Octreotide market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals and Yibin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Octreotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Octreotide, also provides the sales of main regions and countries. Of the upcoming market potential for Octreotide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Octreotide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Octreotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Octreotide sales, projected growth trends, production technology, application and end-user industry.

Octreotide segment by Company

Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide segment by Type

Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide segment by Application

Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Octreotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Octreotide Market by Type
1.2.1 Global Octreotide Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Octreotide Market by Application
1.3.1 Global Octreotide Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Octreotide Market Dynamics
2.1 Octreotide Industry Trends
2.2 Octreotide Industry Drivers
2.3 Octreotide Industry Opportunities and Challenges
2.4 Octreotide Industry Restraints
3 Global Market Growth Prospects
3.1 Global Octreotide Revenue Estimates and Forecasts (2019-2030)
3.2 Global Octreotide Revenue by Region
3.2.1 Global Octreotide Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Octreotide Revenue by Region (2019-2024)
3.2.3 Global Octreotide Revenue by Region (2025-2030)
3.2.4 Global Octreotide Revenue Market Share by Region (2019-2030)
3.3 Global Octreotide Sales Estimates and Forecasts 2019-2030
3.4 Global Octreotide Sales by Region
3.4.1 Global Octreotide Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Octreotide Sales by Region (2019-2024)
3.4.3 Global Octreotide Sales by Region (2025-2030)
3.4.4 Global Octreotide Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Octreotide Revenue by Manufacturers
4.1.1 Global Octreotide Revenue by Manufacturers (2019-2024)
4.1.2 Global Octreotide Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Octreotide Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Octreotide Sales by Manufacturers
4.2.1 Global Octreotide Sales by Manufacturers (2019-2024)
4.2.2 Global Octreotide Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Octreotide Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Octreotide Sales Price by Manufacturers (2019-2024)
4.4 Global Octreotide Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Octreotide Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Octreotide Manufacturers, Product Type & Application
4.7 Global Octreotide Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Octreotide Market CR5 and HHI
4.8.2 2023 Octreotide Tier 1, Tier 2, and Tier 3
5 Octreotide Market by Type
5.1 Global Octreotide Revenue by Type
5.1.1 Global Octreotide Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Octreotide Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Octreotide Revenue Market Share by Type (2019-2030)
5.2 Global Octreotide Sales by Type
5.2.1 Global Octreotide Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Octreotide Sales by Type (2019-2030) & (Gram)
5.2.3 Global Octreotide Sales Market Share by Type (2019-2030)
5.3 Global Octreotide Price by Type
6 Octreotide Market by Application
6.1 Global Octreotide Revenue by Application
6.1.1 Global Octreotide Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Octreotide Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Octreotide Revenue Market Share by Application (2019-2030)
6.2 Global Octreotide Sales by Application
6.2.1 Global Octreotide Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Octreotide Sales by Application (2019-2030) & (Gram)
6.2.3 Global Octreotide Sales Market Share by Application (2019-2030)
6.3 Global Octreotide Price by Application
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Comapny Information
7.1.2 Novartis Business Overview
7.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Novartis Octreotide Product Portfolio
7.1.5 Novartis Recent Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Comapny Information
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Sun Pharmaceutical Octreotide Product Portfolio
7.2.5 Sun Pharmaceutical Recent Developments
7.3 Chengdu Tiantaishan pharmaceutical
7.3.1 Chengdu Tiantaishan pharmaceutical Comapny Information
7.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
7.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
7.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
7.4 Sinopharm A-Think Pharmaceuticals
7.4.1 Sinopharm A-Think Pharmaceuticals Comapny Information
7.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
7.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
7.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
7.5 Sihuan Pharmaceutical Holdings Group
7.5.1 Sihuan Pharmaceutical Holdings Group Comapny Information
7.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
7.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
7.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
7.6 Shanghai Soho-Yiming Pharmaceuticals
7.6.1 Shanghai Soho-Yiming Pharmaceuticals Comapny Information
7.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
7.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
7.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
7.7 Yibin Pharmaceutical
7.7.1 Yibin Pharmaceutical Comapny Information
7.7.2 Yibin Pharmaceutical Business Overview
7.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
7.7.5 Yibin Pharmaceutical Recent Developments
8 North America
8.1 North America Octreotide Market Size by Type
8.1.1 North America Octreotide Revenue by Type (2019-2030)
8.1.2 North America Octreotide Sales by Type (2019-2030)
8.1.3 North America Octreotide Price by Type (2019-2030)
8.2 North America Octreotide Market Size by Application
8.2.1 North America Octreotide Revenue by Application (2019-2030)
8.2.2 North America Octreotide Sales by Application (2019-2030)
8.2.3 North America Octreotide Price by Application (2019-2030)
8.3 North America Octreotide Market Size by Country
8.3.1 North America Octreotide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Octreotide Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Octreotide Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Octreotide Market Size by Type
9.1.1 Europe Octreotide Revenue by Type (2019-2030)
9.1.2 Europe Octreotide Sales by Type (2019-2030)
9.1.3 Europe Octreotide Price by Type (2019-2030)
9.2 Europe Octreotide Market Size by Application
9.2.1 Europe Octreotide Revenue by Application (2019-2030)
9.2.2 Europe Octreotide Sales by Application (2019-2030)
9.2.3 Europe Octreotide Price by Application (2019-2030)
9.3 Europe Octreotide Market Size by Country
9.3.1 Europe Octreotide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Octreotide Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Octreotide Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Octreotide Market Size by Type
10.1.1 China Octreotide Revenue by Type (2019-2030)
10.1.2 China Octreotide Sales by Type (2019-2030)
10.1.3 China Octreotide Price by Type (2019-2030)
10.2 China Octreotide Market Size by Application
10.2.1 China Octreotide Revenue by Application (2019-2030)
10.2.2 China Octreotide Sales by Application (2019-2030)
10.2.3 China Octreotide Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Octreotide Market Size by Type
11.1.1 Asia Octreotide Revenue by Type (2019-2030)
11.1.2 Asia Octreotide Sales by Type (2019-2030)
11.1.3 Asia Octreotide Price by Type (2019-2030)
11.2 Asia Octreotide Market Size by Application
11.2.1 Asia Octreotide Revenue by Application (2019-2030)
11.2.2 Asia Octreotide Sales by Application (2019-2030)
11.2.3 Asia Octreotide Price by Application (2019-2030)
11.3 Asia Octreotide Market Size by Country
11.3.1 Asia Octreotide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Octreotide Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Octreotide Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Octreotide Market Size by Type
12.1.1 MEALA Octreotide Revenue by Type (2019-2030)
12.1.2 MEALA Octreotide Sales by Type (2019-2030)
12.1.3 MEALA Octreotide Price by Type (2019-2030)
12.2 MEALA Octreotide Market Size by Application
12.2.1 MEALA Octreotide Revenue by Application (2019-2030)
12.2.2 MEALA Octreotide Sales by Application (2019-2030)
12.2.3 MEALA Octreotide Price by Application (2019-2030)
12.3 MEALA Octreotide Market Size by Country
12.3.1 MEALA Octreotide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Octreotide Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Octreotide Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Octreotide Value Chain Analysis
13.1.1 Octreotide Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Octreotide Production Mode & Process
13.2 Octreotide Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Octreotide Distributors
13.2.3 Octreotide Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings